These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32037952)

  • 1. APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis.
    Blomain ES; Rappaport JA; Pattison AM; Bashir B; Caparosa E; Stem J; Snook AE; Waldman SA
    Cancer Biol Ther; 2020 May; 21(5):441-451. PubMed ID: 32037952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer.
    Rappaport JA; Entezari AA; Caspi A; Caksa S; Jhaveri AV; Stanek TJ; Ertel A; Kupper J; Fortina PM; McMahon SB; Jaynes JB; Snook AE; Waldman SA
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1276-1296. PubMed ID: 34954189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing the intestinal GUCY2C tumor suppressor axis requires
    Pattison AM; Barton JR; Entezari AA; Zalewski A; Rappaport JA; Snook AE; Waldman SA
    Cancer Biol Ther; 2020 Sep; 21(9):799-805. PubMed ID: 32594830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
    Lin JE; Colon-Gonzalez F; Blomain E; Kim GW; Aing A; Stoecker B; Rock J; Snook AE; Zhan T; Hyslop TM; Tomczak M; Blumberg RS; Waldman SA
    Cancer Res; 2016 Jan; 76(2):339-46. PubMed ID: 26773096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
    Wilson C; Lin JE; Li P; Snook AE; Gong J; Sato T; Liu C; Girondo MA; Rui H; Hyslop T; Waldman SA
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2328-37. PubMed ID: 25304930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.
    Gibbons AV; Lin JE; Kim GW; Marszalowicz GP; Li P; Stoecker BA; Blomain ES; Rattan S; Snook AE; Schulz S; Waldman SA
    Cancer Res; 2013 Nov; 73(22):6654-66. PubMed ID: 24085786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.
    Blomain ES; Merlino DJ; Pattison AM; Snook AE; Waldman SA
    Mol Pharmacol; 2016 Sep; 90(3):199-204. PubMed ID: 27251363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.
    Bashir B; Merlino DJ; Rappaport JA; Gnass E; Palazzo JP; Feng Y; Fearon ER; Snook AE; Waldman SA
    Hum Pathol; 2019 May; 87():103-114. PubMed ID: 30716341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.
    Yarla NS; Gali H; Pathuri G; Smriti S; Farooqui M; Panneerselvam J; Kumar G; Madka V; Rao CV
    Semin Cancer Biol; 2019 Jun; 56():168-174. PubMed ID: 30189250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanylyl cyclase C signaling axis and colon cancer prevention.
    Pattison AM; Merlino DJ; Blomain ES; Waldman SA
    World J Gastroenterol; 2016 Sep; 22(36):8070-7. PubMed ID: 27688649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
    Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
    Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Li P; Wuthrick E; Rappaport JA; Kraft C; Lin JE; Marszalowicz G; Snook AE; Zhan T; Hyslop TM; Waldman SA
    Cancer Res; 2017 Sep; 77(18):5095-5106. PubMed ID: 28916678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
    Lin JE; Li P; Snook AE; Schulz S; Dasgupta A; Hyslop TM; Gibbons AV; Marszlowicz G; Pitari GM; Waldman SA
    Gastroenterology; 2010 Jan; 138(1):241-54. PubMed ID: 19737566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can colorectal cancer be prevented or treated by oral hormone replacement therapy?
    Li P; Lin JE; Schulz S; Pitari GM; Waldman SA
    Curr Mol Pharmacol; 2009 Nov; 2(3):285-92. PubMed ID: 20021465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF-3, 4 protein expression correlates with beta-catenin expression in MSS and MSI-H colorectal cancer from HNPCC patients but not in sporadic colorectal cancers.
    Balaz P; Plaschke J; Krüger S; Görgens H; Schackert HK
    Int J Colorectal Dis; 2010 Aug; 25(8):931-9. PubMed ID: 20532534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
    Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse.
    Li Q; Löhr CV; Dashwood RH
    Cancer Lett; 2009 Sep; 283(1):36-42. PubMed ID: 19376641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer.
    Rappaport JA; Waldman SA
    Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1125-1137. PubMed ID: 32945718
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
    Weinberg DS; Lin JE; Foster NR; Della'Zanna G; Umar A; Seisler D; Kraft WK; Kastenberg DM; Katz LC; Limburg PJ; Waldman SA
    Cancer Prev Res (Phila); 2017 Jun; 10(6):345-354. PubMed ID: 28396341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.